Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pulmonary Neuroendocrine Tumor × surufatinib × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 10 Sarcoma 2 Carcinoma, Neuroendocrine 2 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Pulmonary Neuroendocrine Tumor 1 Pancreatic Neoplasms 1 Neuroendocrine Tumor Grade 3 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Neoplasm Metastasis 1 Differentiated Thyroid Cancer 1 Colorectal Neoplasms 1 Carcinoid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07357623 2026-01-22

Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors

Shanghai Chest Hospital

Phase 2 Recruiting

Pulmonary Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡